Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Fervaha, Gagan
Agid, Ofer
McDonald, Krysta
Foussias, George
and
Remington, Gary
2014.
Daily activity patterns in remitted first-episode schizophrenia.
Comprehensive Psychiatry,
Vol. 55,
Issue. 5,
p.
1182.
Häfner, Heinz
2014.
The Concept of Schizophrenia: From Unity to Diversity.
Advances in Psychiatry,
Vol. 2014,
Issue. ,
p.
1.
Lee, Jimmy
Takeuchi, Hiroyoshi
Fervaha, Gagan
Bhaloo, Amaal
Powell, Valerie
and
Remington, Gary
2014.
Relationship between clinical improvement and functional gains with clozapine in schizophrenia.
European Neuropsychopharmacology,
Vol. 24,
Issue. 10,
p.
1622.
Carbon, Maren
and
Correll, Christoph U.
2014.
Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia.
CNS Spectrums,
Vol. 19,
Issue. S1,
p.
35.
Sicras-Mainar, Antoni
Maurino, Jorge
Ruiz-Beato, Elena
and
Navarro-Artieda, Ruth
2014.
Impact of negative symptoms on healthcare resource utilization and associated costs in adult outpatients with schizophrenia: a population-based study.
BMC Psychiatry,
Vol. 14,
Issue. 1,
Heringa, Sophie M.
Begemann, Marieke J.H.
Goverde, Angelique J.
and
Sommer, Iris E.C.
2015.
Sex hormones and oxytocin augmentation strategies in schizophrenia: A quantitative review.
Schizophrenia Research,
Vol. 168,
Issue. 3,
p.
603.
Kelly, Deanna L.
Sullivan, Kelli M.
McEvoy, Joseph P.
McMahon, Robert P.
Wehring, Heidi J.
Gold, James M.
Liu, Fang
Warfel, Dale
Vyas, Gopal
Richardson, Charles M.
Fischer, Bernard A.
Keller, William R.
Koola, Maju Mathew
Feldman, Stephanie M.
Russ, Jessica C.
Keefe, Richard S. E.
Osing, Jennifer
Hubzin, Leeka
August, Sharon
Walker, Trina M.
and
Buchanan, Robert W.
2015.
Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent Symptoms.
Journal of Clinical Psychopharmacology,
Vol. 35,
Issue. 4,
p.
374.
Fervaha, Gagan
Zakzanis, Konstantine K.
Foussias, George
Agid, Ofer
and
Remington, Gary
2015.
Distress related to subclinical negative symptoms in a non-clinical sample: Role of dysfunctional attitudes.
Psychiatry Research,
Vol. 230,
Issue. 2,
p.
249.
Luther, Lauren
Fukui, Sadaaki
Firmin, Ruth L.
McGuire, Alan B.
White, Dominique A.
Minor, Kyle S.
and
Salyers, Michelle P.
2015.
Expectancies of success as a predictor of negative symptoms reduction over 18 months in individuals with schizophrenia.
Psychiatry Research,
Vol. 229,
Issue. 1-2,
p.
505.
Foussias, George
Siddiqui, Ishraq
Fervaha, Gagan
Agid, Ofer
and
Remington, Gary
2015.
Dissecting negative symptoms in schizophrenia: Opportunities for translation into new treatments.
Journal of Psychopharmacology,
Vol. 29,
Issue. 2,
p.
116.
Hartmann-Riemer, Matthias N.
Hager, Oliver M.
Kirschner, Matthias
Bischof, Martin
Kluge, Agne
Seifritz, Erich
and
Kaiser, Stefan
2015.
The association of neurocognitive impairment with diminished expression and apathy in schizophrenia.
Schizophrenia Research,
Vol. 169,
Issue. 1-3,
p.
427.
Fervaha, Gagan
Duncan, Mark
Foussias, George
Agid, Ofer
Faulkner, Guy E.
and
Remington, Gary
2015.
Effort-based decision making as an objective paradigm for the assessment of motivational deficits in schizophrenia.
Schizophrenia Research,
Vol. 168,
Issue. 1-2,
p.
483.
Fervaha, Gagan
Foussias, George
Agid, Ofer
and
Remington, Gary
2015.
Motivational deficits in early schizophrenia: Prevalent, persistent, and key determinants of functional outcome.
Schizophrenia Research,
Vol. 166,
Issue. 1-3,
p.
9.
Jaracz, K.
Górna, K.
Kiejda, J.
Grabowska-Fudala, B.
Jaracz, J.
Suwalska, A.
and
Rybakowski, J.K.
2015.
Psychosocial functioning in relation to symptomatic remission: A longitudinal study of first episode schizophrenia.
European Psychiatry,
Vol. 30,
Issue. 8,
p.
907.
Foussias, G.
Siddiqui, I.
Fervaha, G.
Mann, S.
McDonald, K.
Agid, O.
Zakzanis, K.K.
and
Remington, G.
2015.
Motivated to do well: An examination of the relationships between motivation, effort, and cognitive performance in schizophrenia.
Schizophrenia Research,
Vol. 166,
Issue. 1-3,
p.
276.
Stricklin, Suzanne
Perry, Luke A
and
Ramson, Dhruvesh
2015.
Mirtazapine (adjunct) versus placebo for schizophrenia.
Cochrane Database of Systematic Reviews,
Chang, Wing Chung
Lau, Charles Fu Chun
Chan, Sherina Suet In
Hui, Christy Lai Ming
Chan, Sherry Kit Wa
Lee, Edwin Ho Ming
Lin, Jingxia
and
Chen, Eric Yu Hai
2016.
Premorbid, clinical and cognitive correlates of primary negative symptoms in first-episode psychosis.
Psychiatry Research,
Vol. 242,
Issue. ,
p.
144.
Bull, Helen
Ueland, Torill
Lystad, June Ullevoldsæter
Evensen, Stig
Martinsen, Egil Wilhelm
and
Falkum, Erik
2016.
Vocational Functioning in Schizophrenia Spectrum Disorders.
Journal of Nervous & Mental Disease,
Vol. 204,
Issue. 8,
p.
599.
Egger, Stephan T.
Vetter, Stefan
Weniger, Godehard
Vandeleur, Caroline
Seifritz, Erich
and
Müller, Mario
2016.
The Use of the Health of the Nation Outcome Scales for Assessing Functional Change in Treatment Outcome Monitoring of Patients with Chronic Schizophrenia.
Frontiers in Public Health,
Vol. 4,
Issue. ,
Battal Merlet, L.
Blanchet, A.
Lockman, H.
and
Kostova, M.
2016.
How semantic content of stimuli works on episodic memory processes in negative schizophrenia: Evidence from picture recognition.
European Review of Applied Psychology,
Vol. 66,
Issue. 5,
p.
211.
Comments
No Comments have been published for this article.